Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for bleeding reduction in septorhinoplasty
IRCT20230715058778N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of clonidine in perioperative bleeding (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Blood pressure and Bleeding. Started Aug 2023; status: completed.
02
Drugs
clonidine
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on IRCT20230715058778N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230715058778N1.